CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 86 filers reported holding CUREVAC N V in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -50.0% | 183 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | +100.0% | 183 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 183 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 183 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 183 | -17.6% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 222 | -2.6% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 228 | +24.6% | 0.00% | – |
| Q4 2021 | $6,000 | -25.0% | 183 | +69.4% | 0.00% | – |
| Q2 2021 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | 0.0% | 108 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | – | 108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $13,500,000 | 10.67% |
| FOX RUN MANAGEMENT, L.L.C. | 31,522 | $248,000 | 0.10% |
| Green Alpha Advisors, LLC | 12,598 | $99,000 | 0.08% |
| Quantamental Technologies LLC | 10,846 | $85,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 49,034 | $386,000 | 0.03% |
| Virtus ETF Advisers LLC | 7,733 | $61,000 | 0.02% |
| XTX Topco Ltd | 12,040 | $95,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 55,320 | $436,000 | 0.01% |
| TWINBEECH CAPITAL LP | 46,360 | $365,000 | 0.01% |
| Man Group plc | 281,996 | $2,222,000 | 0.01% |